看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
! [& f; w' l: Z4 ^- ]
6 {; m. A8 D8 I& ^' O, \
$ K, E8 P& s6 b8 W* z8 l7 ]% cCurrently available feasibility data for possible combination strategies.
4 I& C( z. Y* g* c# e" D————————————————————————————————# L+ z6 A+ Z5 `+ K, P& t
Combination Feasibility according to preliminary data
& A8 z! q& g# l——————————————————————————————————7 w% |' G c) T8 m3 T2 }
Bevacizumab + sorafenib Yes, reduced dose
& W5 \2 }; i3 A2 WBevacizumab + sunitinib† No ! p9 Q* @* j* O
Bevacizumab + temsirolimus Yes
$ |1 t* o8 \7 k9 H% s* S) kBevacizumab + everolimus Yes
, _5 J+ R' \: n% RSorafenib + sunitinib ?
' V) y3 l6 [* F9 e! @1 n" dSorafenib + temsirolimus Yes, reduced dose ; |1 [" E6 O$ H$ |- |6 Q
Sorafenib + everolimus Yes, reduced dose
* c9 ^+ S0 o* d6 B& I3 [- D" X1 gSunitinib + temsirolimus† No . w- {' g5 b! ` N3 f& R
Sunitinib + everolimus ? / ?) `* f; _( s8 ^) [
Temsirolimus + everolimus ? : i% e. ]6 w. A; s3 o
————————————————————
" i n: G8 d) i6 r; H†Led to US FDA warning.4 c* w& g9 m& R% O
?: As yet unattempted combination.
: W8 @8 z) q) h6 F5 ~$ c4 \ |